Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > Articles online first > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 Jan 26

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 Jan 26

DOI: 10.23736/S1824-4785.21.03334-3

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Medical treatment of thyrotoxicosis

Lorenzo SCAPPATICCIO 1 , Giuseppe BELLASTELLA 1, 2, Maria Ida MAIORINO 1, 2, Luca GIOVANELLA 3, 4, Katherine ESPOSITO 2, 5

1 Unit of Endocrinology and Metabolic Diseases, University of Campania L. Vanvitelli, Naples, Italy; 2 Department of Advanced Medical and Surgical Sciences, University of Campania L. Vanvitelli, Naples, Italy; 3 Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland; 4 Clinic for Nuclear Medicine, University Hospital and University of Zurich, Zurich, Switzerland; 5 Diabetes Unit, University of Campania L. Vanvitelli, Naples, Italy


PDF


Medical treatment is the primary therapeutic option for thyrotoxicosis/hyperthyroidism. Two groups of causes of thyrotoxicosis (i.e. thyrotoxicosis with hyperthyroidism and thyrotoxicosis without hyperthyroidism) need to be considered for therapeutic reasons. Herein we provide an updated review on the role of conventional medical therapies [i.e. β-blockers, anti-thyroid drugs (ATDs), corticosteroids, inorganic iodide, perchlorate, cholecystographic agents, lithium, cholestyramine] in the main causes of thyrotoxicosis, starting from the rationale subtending their clinical application.


KEY WORDS: Thyrotoxicosis; Hyperthyroidism; Therapy; Drugs

inizio pagina